Related Experiment Video
Updated: Mar 3, 2026

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Oral Contraceptives after Bariatric Surgery.
1Department of Pharmacy, Hôpital Jean Verdier - APHP, Hôpitaux Universitaires de Paris-Seine-Saint-Denis, Bondy, France.
Bariatric surgery can alter oral drug absorption, impacting medication effectiveness. Oral contraceptives require careful consideration post-surgery, with implants potentially offering a safer alternative for women.
Area of Science:
- Pharmacology and Gastroenterology
- Drug absorption and bioavailability
- Bariatric surgery outcomes
Background:
- Bariatric surgery is a key treatment for obesity.
- Gastrointestinal tract alterations post-surgery can affect oral drug uptake.
- Understanding drug bioavailability changes is crucial for patient management.
Purpose of the Study:
- To review literature on the efficacy and adequacy of oral drugs after bariatric surgery.
- To specifically assess the effectiveness of oral contraceptives in this patient group.
- To identify potential risks and alternative strategies for medication management.
Main Methods:
- Systematic literature assessment.
- Focus on studies evaluating oral drug and oral contraceptive use post-bariatric procedures.
- Analysis of factors influencing drug bioavailability and absorption.
Main Results:
- Altered gastrointestinal pH, solubility, and transporter function can impact drug bioavailability.
- Transient absorption changes affect various drug classes, including analgesics, antibiotics, and oral contraceptives.
- Implants may be a safer contraceptive option for women post-bariatric surgery.
Conclusions:
- Individual drug absorption profiles must be evaluated based on absorption site and mechanism.
- Parameters influencing absorption effectiveness require careful consideration.
- Personalized medication management strategies are essential after bariatric interventions.
Related Concept Videos
Birth Control Methods
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Intrauterine Drug Delivery Systems
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

